$OSUR News
Last published 2d ago
- 2d agoOSURORASURE TECHNOLOGIES INC - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 2d agoOSUROraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin ExpansionGlobeNewswireBETHLEHEM, Pa., Nov. 09, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended September 30, 2026.
- 2d agoOSUROraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin ExpansionGlobeNewswire14% year-over-year revenue growth in the quarter highlights effectiveness of return-to-growth strategyGAAP gross margin improved by over 170 bps vs. prior year to 45.2%Received initial orders of Colli-Pee®•Dx and
- 2d agoOSUROraSure Technologies Inc. 2026 Third Quarter Earnings Conference Call - ORASURE TECHNOLOGIES INCEarnings Call TranscriptsGood day, and welcome to the Aura Assured Technologies, Inc., 2026 Third Quarter Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a questio
- 2d agoOSUROraSure Technologies Inc. 2026 Third Quarter Earnings Conference Call - ORASURE TECHNOLOGIES INCEarnings Call TranscriptsGood day, and welcome to the Aura Assured Technologies, Inc., 2026 Third Quarter Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a questio
- 2w agoOSUROraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9thGlobeNewswireBETHLEHEM, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that it will report its third quarter 2026 financial results on Monday, November 9, 2026, after the market
- 3mo agoOSUROraSure Announces Second Quarter 2026 Financial ResultsGlobeNewswireBETHLEHEM, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results
- 3mo agoOSUROraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5thGlobeNewswireBETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market
- 3mo agoOSUROraSure Receives Emergency Use Authorization for Second Generation Ebola TestGlobeNewswireBETHLEHEM, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that it has
- 5mo agoOSUROraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted InfectionsGlobeNewswireBETHLEHEM, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OraSure") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions today announced U.S. Food and
- 6mo agoOSUROraSure Announces First Quarter 2026 Financial ResultsGlobeNewswireBETHLEHEM, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for
- 6mo agoOSUROraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6thGlobeNewswireBETHLEHEM, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering first quarter 2026 financial results and certain business
- 6mo agoOSUROraSure Technologies Appoints John D. Bertrand to its Board of DirectorsGlobeNewswireEnters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc.
- 7mo agoOSURAltai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued UnderperformanceBusiness WireCalls on Company to Reach a Fair Settlement that Appoints Altai Nominees Rishi Bajaj and John Bertrand to the Board Altai Capital Management, L.P. ("Altai"), one of the largest shareholders and the beneficial
- 8mo agoOSUROraSure Technologies Inc. 2025 Fourth Quarter Earnings Conference Call - OraSure Technologies Inc.Earnings Call TranscriptsGood day and thank you for standing by. Welcome to the Aura Shore Technologies 2025 Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, the
- 8mo agoOSUROraSure Announces Fourth Quarter 2025 Financial ResultsGlobeNewswireBETHLEHEM, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for
- 9mo agoOSUROraSure to Launch OraQuick™ HIV Self-Test in CanadaGlobeNewswireBETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OraSure") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its
- 9mo agoOSUROraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25thGlobeNewswireBETHLEHEM, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering fourth quarter 2025 financial results and certain business
- 10mo agoOSUROraSure Technologies Confirms Receipt of Director Nominations from Altai CapitalGlobeNewswireBETHLEHEM, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OraSure" and "OTI") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today confirmed
- 10mo agoOSUROraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA ReviewGlobeNewswireBETHLEHEM, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) ("OraSure" and "OTI"), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced
- 10mo agoOSUROraSure Technologies Issues Statement Regarding Altai Capital's Intent to Nominate Director CandidatesGlobeNewswireBETHLEHEM, Pa., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OraSure" and "OTI") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today confirmed
- 10mo agoOSURAltai Capital Management Announces Intention to Nominate Two Highly-Qualified Candidates for Election to OraSure Board of DirectorsBusiness WireIssues Letter Outlining Company's Failure to Deliver Value to Shareholders Altai Capital Management, L.P. ("Altai"), one of the largest shareholders and beneficial owners of approximately 5.2% of the outstanding common
- 11mo agoOSUROraSure to Participate in Upcoming Investor ConferenceGlobeNewswireBETHLEHEM, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that the company is scheduled to participate in the following investor conference: Stephens Annual Investment
- 1y agoOSUROraSure Technologies Inc. 2025 Third Quarter Earnings Conference Call - OraSure Technologies Inc.Earnings Call TranscriptsLadies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Autoshare Technologies, Inc. 2025 3rd Quarter Air Nakes Conference Call. All lines have been placed on mute to preven
- 1y agoOSUROraSure Announces Third Quarter 2025 Financial ResultsGlobeNewswireBETHLEHEM, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for
- 1y agoOSUROraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5thGlobeNewswireBETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business
- 1y agoOSUROraSure Technologies Appoints Steven K. Boyd to its Board of DirectorsGlobeNewswireSeasoned Investor with Deep Experience in the Healthcare and Medical Device Industries Brings Valuable Capital Markets Expertise and Investor Perspective OraSure Board Has Added Three New Independent Directors in the
- 1y agoOSUROraSure Technologies, Inc. (OSUR) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoOSUROraSure Announces Second Quarter 2025 Financial ResultsGlobeNewswireBETHLEHEM, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for
- 1y agoOSUROraSure Appoints Anne Messing as Chief Commercial OfficerGlobeNewswireBETHLEHEM, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OTI") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that Anne Messing
- 1y agoOSUROraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5thGlobeNewswireBETHLEHEM, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering second quarter 2025 financial results and certain business
- 1y agoOSUROraSure Launches Novel Blood Collection Device for Proteomic ResearchGlobeNewswireBETHLEHEM, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OTI") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the launch of its
- 1y agoOSURTargeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic TestingGlobeNewswireIRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the first and only U.S. Food and Drug Administration (FDA) cleared direct-to-consumer (DTC) test for celiac disease
- 1y agoOSUROraSure Announces First Quarter 2025 Financial ResultsGlobeNewswireBETHLEHEM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for
- 1y agoOSUROraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7thGlobeNewswireBETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business
- 1y agoOSUROraSure Announces $40 Million Stock Repurchase ProgramGlobeNewswireBETHLEHEM, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (the "Company") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that its
- 1y agoOSUROraSure Reports Fourth Quarter 2024 Financial ResultsGlobeNewswireBETHLEHEM, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for
- 1y agoOSUROraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25thGlobeNewswireBETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering fourth quarter 2024 financial results and certain business
- 1y agoOSUROraSure to Present at the J.P Morgan Healthcare ConferenceGlobeNewswireBETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that members of its
- 1y agoOSURCORRECTION - OraQuick® HIV Self-Test Now Approved for Use in AdolescentsGlobeNewswireBETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. (NASDAQ:OSUR), please note that the first sentence of the release
- 1y agoOSUROraQuick® HIV Self-Test Now Approved for Use in AdolescentsGlobeNewswireBETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraQuick® HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14 years of
- 1y agoOSUROraSure Technologies Acquires Sherlock BiosciencesGlobeNewswireBETHLEHEM, Pa., Dec. 19, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OTI") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the acquisition
- 1y agoOSUROraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen TestGlobeNewswireBETHLEHEM, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions, today announced that it received an award
- 1y agoOSUROraSure to Participate in Upcoming Investor ConferenceGlobeNewswireBETHLEHEM, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that the company is scheduled to participate in the following investor conference: Stephens Annual Investment
- 2y agoOSUROraSure Technologies, Inc. (OSUR) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoOSUROraSure Reports Q3 '24 Revenue of $39.9 MillionGlobeNewswireQ3 GAAP EPS of $(0.06); Q3 Non-GAAP EPS of $(0.01) OraQuick® HCV Self-test receives initial orders following receipt of WHO pre-qualification status Expanding Sample Management applications into blood proteomics
- 2y agoOSUROraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6thGlobeNewswireBETHLEHEM, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering third quarter 2024 financial results and certain business
- 2y agoOSUROraSure Technologies Elects Jack Kenny to the Board of DirectorsGlobeNewswireBETHLEHEM, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced the election of Jack
- 2y agoOSUROraSure Technologies Inc (OSUR) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoOSUROraSure Reports Q2 '24 Revenue of $54.3 MillionGlobeNewswireQ2 GAAP EPS of $(0.01); Q2 Non-GAAP EPS of $0.07 OraQuick® HCV Self-test is the first globally to earn WHO pre-qualification Strong momentum with Syphilis Health Check™ launch Expanding Sample Management